A detailed history of Wambolt & Associates, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Wambolt & Associates, LLC holds 442 shares of IDXX stock, worth $186,042. This represents 0.06% of its overall portfolio holdings.

Number of Shares
442
Previous 421 4.99%
Holding current value
$186,042
Previous $205,000 8.78%
% of portfolio
0.06%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$455.08 - $517.19 $9,556 - $10,860
21 Added 4.99%
442 $223,000
Q2 2024

Aug 07, 2024

BUY
$468.04 - $548.53 $197,044 - $230,931
421 New
421 $205,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $35B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Wambolt & Associates, LLC Portfolio

Follow Wambolt & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.